Ignite Creation Date:
2025-12-24 @ 1:17 PM
Ignite Modification Date:
2026-02-22 @ 4:15 PM
Study NCT ID:
NCT03094195
Status:
TERMINATED
Last Update Posted:
2021-10-08
First Post:
2017-03-23
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Dose Response Study of EMA401 in Patients With Post-herpetic Neuralgia (PHN)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-06-27
Start Date Type:
ACTUAL
Primary Completion Date:
2019-03-07
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-03-07
Completion Date Type:
ACTUAL
First Submit Date:
2017-03-23
First Submit QC Date:
None
Study First Post Date:
2017-03-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2020-03-06
Results First Submit QC Date:
None
Results First Post Date:
2020-05-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-07
Last Update Post Date:
2021-10-08
Last Update Post Date Type:
ACTUAL